MEEDER ASSET MANAGEMENT INC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$3,000
-25.0%
2,946
+21.5%
0.00%
Q4 2018$4,000
-69.2%
2,425
+7.4%
0.00%
-100.0%
Q3 2018$13,000
-99.7%
2,257
+99.7%
0.00%
Q2 2018$4,836,000
+96620.0%
1,130
+22.3%
0.00%
Q1 2018$5,000
-54.5%
924
-61.1%
0.00%
-100.0%
Q4 2017$11,0002,3760.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders